Navigation Links
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
Date:7/18/2011

dian age 58, with advanced stage mantle cell lymphoma treated with one of the two therapies. The model was not validated for these patients. The authors conclude that the study highlights the need to develop and validate models that can identify patients treated with dose-intensive approaches who are at risk for poor survival.

Association between chronic myeloid leukemia (CML) treatment responses and patient satisfaction, functioning, and quality of life (QOL): Patient survey results.

Stuart L. Goldberg, M.D. and colleagues assessed patients' awareness of chronic myeloid leukemia (CML) treatment response categorizations and the association between treatment responses and satisfaction, functioning, and quality of life. Patients were invited to participate in an online survey through the Association for Cancer Online Resources; 123 responded. Nearly all reported they were in complete hematological response. In this well-educated population (96% had some college), 90% of patients were aware of the different treatment response categories. However, 71.5% felt CML patients need more information on types of responses, with the desire for information to come from their physicians (67%) versus other staff (28%) or pamphlets (24%). Patients achieving major molecular response to treatment (MMR) had higher overall self- reported health status versus patients in complete cytogenetic response (CCyR). Complete cytogenetic response is the absence of the defective chromosome that causes the disease, while major molecular response is defined as a level of .1 percent or lower of the BCR-ABL oncoprotein as measured by a more sensitive test than traditional cytogenetic analysis. The authors conclude that from the patients' perspective, achievement of MMR is an important milestone associated with improved satisfaction with their physician, medication, daily functioning, and outlook on life. Additional research is needed to assess the best ways to help patients understand diff
'/>"/>

Contact: Amy Leahing
Amy.leahing@zibbel.com
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. John Theurer Cancer Center BMT researchers highlight the importance of social support
2. Cancer stem cells recruit normal stem cells to fuel ovarian cancer, U-M study finds
3. Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients
4. UT Southwestern research reveals that significantly more genetic mutations lead to colon cancer
5. Cancer gene therapy from camels
6. Cancer data not readily available for future research
7. UT faculty improving surgical outcomes for children, cancer patients
8. Study explains why men are at higher risk for stomach cancer
9. Stem cells restore cognitive abilities impaired by brain cancer treatment
10. PSA test for men could get a second life for breast cancer in women
11. Low dose naltrexone (LDN): Harnessing the bodys own chemistry to treat human ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/24/2015)... 2015 Research and ... the "Huawei Ascend Mate 7 Fingerprint Sensor ... offering. Huawei,s technological choice for the ... than Apple,s and Samsung,s one. The Ascend Mate ... Fingerprint Cards, a main actor in capacitive sensing ...
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... issue of Genes & Development, Dr. Mary Ellen Perry ... promising target for cancer therapies. , The p53 tumor ... many anticancer strategies aim to activate p53 in order ... of p53 and therefore an attractive target to modulate ...
... physicists at the University of California, San Diego has shown ... as it passes through tiny pores. The advance brings ... in the April issue of the journal Nano Letters, describes ... of hours at a potentially low cost, by measuring the ...
... serious suicide attempts or death by suicide generally decreases ... according to a new study led by Group Health ... The American Journal of Psychiatry. The study also found ... newer antidepressant medications is less than the risk posed ...
Cached Biology News:Nanopore method could revolutionize genome sequencing 2Nanopore method could revolutionize genome sequencing 3Suicide risk does not increase when adults start using antidepressants, study finds 2
(Date:7/24/2015)... ... July 24, 2015 , ... RURO’s ... modern scientific or pharmaceutical laboratory. FreezerPro® is an intuitive, fast, reliable and ... a sample is located even before opening the freezer door! Popular features ...
(Date:7/23/2015)... ... ... One hundred years ago this year, 18 model airplane clubs competed in the ... the Henry S. Villard Trophy. The Academy of Model Aeronautics has plans to reenact ... a Free Flight fantasy club worthy of taking home the Villard Trophy. After extensive ...
(Date:7/23/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), are pleased to announce ... (IND) Application with the U.S. Food and Drug ... Portage holds 54% equity interest in Biohaven, a ... modulating agent and Biohaven has entered into an ...
(Date:7/23/2015)... , ... July 23, 2015 , ... Global Stem ... research in Santiago, Chile. The symposium will feature some of the world’s most ... day of high-level scientific discussion for medical professionals in general practice. , The ...
Breaking Biology Technology:RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 2RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 3RURO, Inc. Partners with Integrated Systems Engineering to Provide Comprehensive LIMS Software to Biobanks 4Academy of Model Aeronautics to Start Online Fantasy Flight Competition 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 2Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 3Portage's Biohaven Announces IND Filing for BHV-0223 for Phase 1 Clinical Testing 4Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015 2Global Stem Cells Group Announces Plans to Hold International Symposium on Stem Cells and Regenerative Medicine in Santiago, Chile Sept. 3-4, 2015 3
... Calif., May 1 TorreyPines Therapeutics, Inc. (Nasdaq: ... ended March 31, 2009. For the three-month ... Cash and cash equivalents totaled $6.3 million at March ... Ford as its financial advisor to assist in the evaluation ...
... Fincor (Pink Sheets: FINC) through a share ... leading company in the field of water technologies, enlarges its ... Fincor also acquired the WETTECH and Advanced Cavitation Technologies. ... several natural drugs to fight Malaria and Dengue fever and ...
... Board of Directors Also Appoints a New President and ... Perrin, Ph.D., was appointed chief executive officer and Maureen ... Institute (ALS TDI) during the annual meeting of its ... passing of Sean Scott, the Institute,s previous president, due ...
Cached Biology Technology:TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 2TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 3TorreyPines Therapeutics Reports First Quarter 2009 Financial Results 4Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment 2ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 2ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 3
... The DNA quantitation kit is used to ... the presence of RNA or protein. With this ... which can be detected with a VersaFluor or ... range of 10 ng per ml to 5 ...
... stimulating factors for assays of mouse hematopoietic ... fetal liver. Suitable for the growth ... when added to methylcellulose at a final ... Will also support growth of mouse ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
...
Biology Products: